Cadrenal Therapeutics CEO Quang Pham's 2023 pay rises 18% to $967K
Cadrenal Therapeutics reports 2023 executive compensation
By ExecPay News
Published: June 11, 2024
Cadrenal Therapeutics reported fiscal year 2023 executive compensation information on June 11, 2024.
In 2023, three executives at Cadrenal Therapeutics received on average a compensation package of $780K, a 28% increase compared to previous year.
Average pay of disclosed executives at Cadrenal Therapeutics
Quang Pham, Chief Executive Officer, received $967K in total, which increased by 18% compared to 2022. 69% of Pham's compensation, or $663K, was in salary. Pham also received $293K in bonus and $12K in other compensation.
Matthew Szot, Chief Financial Officer, received a compensation package of $845K, which increased by 135% compared to previous year. 45% of the compensation package, or $377K, was in salary.
Douglas Losordo, Chief Medical Officer, earned $529K in 2023, a 18% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on June 11, 2024.